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What is already known about this subject? 
Health professionals should not return to work until they will no longer transmit the 
disease. The most extended protocol requires the health worker to be free of COVID-19 
symptoms and to have at least one negative PCR for SARS-CoV-2.  
What are the new findings? 
In this study with a development cohort of 159 healthcare workers, and using survival 
analysis, we defined the variables that influence PCR time to negativization. Median 
time to negativization was 25 days from symptom onset. Workers with dry cough and 
dyspnea needed nearly one week more to negativizate. 
How might it impact on clinical practice in the foreseeable future? 




Survival analysis of time to SARS-CoV-2 PCR negativization to optimize PCR 
prescription in health workers: the Henares COVID-19 healthcare workers cohort 
study. 
 
AimObjectives: Reverse-transcriptase polymerase-chain-reaction (RT-PCR) is 
considered the gold standard for diagnosing coronavirus disease 2019 (COVID19). 
Infected healthcare workers don´t go back to work until RT-PCR has demonstrated that 
the virus is no longer present in the upper respiratory tract. The aim of this study is to 
determine the most efficient time to perform a RT-PCR prior to their reincorporation. 
Material and methods: Cohort study of those health workers with RT-PCR confirmed 
COVID-19.  Data was collected using the medical charts of the health workers and 
completed with a telephone interview. Kaplan-Meier curves were used to determine the 
influence of several variables in the time to RT-PCR negativization. The impact of the 
variables in survival was assessed using the Breslow test. A Cox regression model was 
developed including the associated variables. 
Results: 159 subjects with a positive RT-PCR out of 374 workers with suspected 
COVID-19 were included. Median time to negativization was 25 days from symptom 
onset (interquartilic range 20 to 35 days). Presence of Ig G, dyspnea, cough and throat 
pain were associated with significant longer times to negativization.
  Cox logistic regression was used to eliminate confounding variables. Only dyspnea 
  Cox logistic regression was used to eliminate confounding variables. Only dyspnea 
  
Cox logistic regression was used to eliminate 
confounding variables. Only dyspnea and cough remained in the model as significant 
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determinants of prolonged negativization times. Adjusted hazard ratios were 0.68(0.48-
096)) for dyspnea and 0.61(0.42-0.88) for dry cough. 
Conclusions: RT-PCR during the first three weeks leads to a high percentage of positive 
results.  In the presence of respiratory symptoms, negativization took nearly one week 
more. Those who developed antibodies needed  longer times to negativizate. 
 
Introduction 
In December 2019, an outbreak of atypical pneumonia occurred in Wuhan (China). 
Days later a new coronavirus was identified as the responsible agent. In a few weeks, 
due to the lack of immunity and the high transmissibility of the virus, the infection had 
spread worldwide causing thousands of deaths.(1, 2)  
Spain has one of the highest number of confirmed infections.(3) The Henares catchment 
area was one of the most severely hit by the pandemic, and a significant number of 
healthcare professionals became infected. The occupational medicine department was 
overwhelmed and unable to cope with this severe and unexpected crisis and a new 
specific task force composed by both physicians from different specialties and nurses 
was set up to help manage the pandemic. In April of 2020 the Henares COVID cohort 
health workers study was initiated with the purpose of investigating this new disease.  
It is easier to garner comprehensive information from cohorts of healthcare workers 
than general population, since they define more precisely their symptoms, have a more 
direct access to diagnostic technology and are usually keener to participate because they 
are constantly dealing with patients and understand the need for thorough studies.  
Thereby several previous cohort studies have followed healthcare workers (4, 5). In the 
Con formato: Fuente: (Predeterminada) Times New
Roman, Color de fuente: Fondo 2
6 
 
case of COVID-19 this population has a demonstrated higher incidence of infection, 
thus making it easier to gather a significant sample. 
In order to keep their workplace as safe as possible for both staff and patients, health 
professionals should not return to work until they will no longer transmit the disease (6).  
Several protocols have been proposed. Our center adhered to the protocol recommended 
by the CDC at that time, requiring at least two negative reverse transcriptase-
polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 in a nasopharyngeal 
swab prior to return to work. In order to maintain an adequate workforce, it is important 
to allow healthcare workers to return as soon as possible, but, especially if there is 
limited capacity for RT-PCR testing, it is necessary to optimize its performance.  
Therefore, the aim of this study was to estimate the most efficient time-frame to do a 
RT-PCR prior to return to work.  
Material and methods  
Patients and study design 
The Henares COVID-19 healthcare workers cohort study was designed as a combined 
prospective and retrospective cohort study. This cohort included all those healthcare 
workers who consulted with clinical manifestations compatible with COVID 19 (Fever 
and/or pseudo-flue syndrome or/and digestive symptoms or/and chemosensory 
disorders) at Hospital Universitario del Henares from 11th of March 2020 and the 31st of 
April 2020. This center is a secondary care hospital, located in the region of Madrid, 
with a catching area of 175,000 inhabitants. 
 
 To be included in the cohort patients had to have at least one confirmatory upper 
respiratory tract RT-PCR for SARS-CoV-2.  A survival analysis was performed to 
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determine time to negativization, which was calculated as the difference between the 
date of the first of the two consecutive negative RT-PCR and the date of patient-
estimated symptom onset. Patients with at least two weeks of follow up were included 
in the study. 
The electronic chart of the workers was reviewed and data transcribed to an Excel sheet 
by one of the authors of the study. An additional personal phone interview conducted by 
the same doctor who introduced the data was scheduled for each patient, to resolve 
missing or contradictory data. Then patients were followed in a prospective fashion 
until PCR negativization took place, registering the results of each PCR. Data were 
analyzed using SPSS software program, version 15.0 (SPSS, Chicago, Illinois). The study was 
approved by the Clinical Research Ethics Committee of Universidad Francisco de 
Vitoria and by the Research Committee of University Hospital of Henares, and all the 
workers expressed their consent signing an authorization form or affirmatively replying 
to an email. 
Demographic data including age, date of birth, gender, professional activity, height and 
weight at the onset of symptoms, date of symptom onset, blood type, smoking status 
and date of positive PCR for SARS-CoV-2 were collected. The presence of the 
following comorbidities was also recorded: high blood pressure, treatment with 
angiotensin-converting enzyme inhibitors, diabetes mellitus, ischemic heart disease, 
stroke, lung disease (asthma or obstructive pulmonary disease). All these risk factors 
were collected as binary variables except tobacco exposure, which was stratified as mild 
(1-9 cigarettes per day), moderate (10-19 cigarettes per day) and severe (more than 20 
cigarettes per day). Binary data related to 14 clinical manifestations was also collected: 
fever, rhinorrhea, throat pain, cough dry/productive, headache, myalgia, dyspnea, 
tachycardia, hyposmia/hypogeusia, asthenia, digestive manifestations (diarrhea, nausea 
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or vomiting), conjunctivitis, dermatological manifestations. The maximum body 
temperature reached was also registered in those patients who referred fever. When the 
patient referred dyspnea, a chest radiography was performed. The result of the chest 
radiography and the most aggressive clinical management required (ambulatory, 
conventional hospitalization or intensive care unit hospitalization) as well as the date of 
PCR negativization were also collected.  
Statistical analysis was performed with SPSS 15.0 software (IBM Corp, Armonk, NY, 
USA).  Continuous variables were presented as mean ± standard deviation if normally 
distributed, and as median and interquartile range (IQR) if non-normally distributed. A 
two-tailed P < 0.05 was considered statistically significant.  
Bivariate analysis of time to RT-PCR negativization was performed through the study of 
Kaplan-Meier curves and statistical significance was performed using the Breslow test. 
Demographic variables (age, gender and BMI) and those clinical variables that were 
associated in the Breslow test were included in a multivariate analysis using Cox 
proportional hazards models. A backward-conditional method was chosen, with 
significance levels of 0.05 for inclusion and 0.1 for exclusion.  
Results 
399 healthcare workers were attended for suspected COVID 19, between the 11th of 
March 2020 and the 31st of April 2020 (Figure 1). In 374 cases, patients had clinical 
manifestations compatible with COVID and a sample for RT-PCR of the upper 
respiratory tract was obtained. Of these, in 159 cases the presence of SARS Cov-2 was 
confirmed with RT PCR; these patients were included in the COVID-19 PCR positive 
cohort. (Figure 1) Demographic characteristics are summarized in table 1. Mean age 
was 41.3 years, and women made up almost four-fifths of the sample. As regards 
profession, 35.2% were nurses, 32.7% physicians and 22.6 % heath technicians. This 
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distribution mirrors the composition of the hospital staff (41% registered nurses, 28% 
medical doctors, and 29 % health technicians).  
Most of the sample (74.2%) was composed by healthy subjects. Only 20.8% had one 
medical condition, and 3.1% had two conditions. Asthma was the most common 
comorbidity (9.4%), followed by high blood pressure (5%). Only 10.2% of the members 
of the cohort were smokers.  
Chest radiography demonstrated the presence of pneumonia in 27 patients. Most of the 
patients received only symptomatic treatment. Only 22 patients (17%) received specific 
treatment for COVID 19. Only eleven patients were admitted into the hospital; 10 of 
them needed conventional hospitalization and one needed intensive care hospitalization. 
74% of the patients in the cohort reported hyperthermia, mostly low fever: only 24% of 
patients reported a maximal temperature above 38.0ºC. Cough was the most common 
symptom; 65.4% referred dry cough while 7.5% referred productive cough. Headache, 
muscle pain, asthenia and some degree of hyposmia or taste alteration was present in a 
similar number of subjects (Table 1). 
 
 
 Studied variables 
Demographic variables (n=159) 
Age (mean; SD) Mean=41.3; SD=11.7 
Women 126 (79.2%) 
Body mass index (BMI)  Mean=24.8; SD=4.7 
Comorbidities  
High blood pressure 8 (5%) 
Diabetes mellitus 3 (2%) 
Ischemic heart disease 0 
Ictus 0 
Tobacco exposure 0 cig: 143 (89%) 
1-10 cig: 12 (8%) 




Clinical manifestations  
Fever No fever: 41 (25.8%) 
Low fever: 81 (56.9%) 
Moderate fever: 34 (21.4%) 
High fever:  3 (1.9%) 
Maximum body temperature 38ºC   SD=0.7ºC 
Rhinitis 40 (25.2%) 
Hyposmia/hypogeusia 111 (69.8%) 
Throat pain 59 (36.9%) 
Cough (dry/productive) 104 (65.4%)/ 12 (7.5%) 
Headache 104 (65.4%) 
Myalgia 107 (67.3%) 
Dyspnea 60 (37.5%) 
Tachycardia 28 (17.6%) 
Asthenia 94 (59.1%) 




Table 1. Demographic data, main comorbidities and clinical manifestations during the 
course of disease. 
 
Median time to negativization was 25 days from symptom onset (interquartile range 23 
to 27 days). The influence of several symptoms on the speed of negativization was 
analyzed using Kaplan Meier curves (Figure 2). The Breslow test was used to determine 
the influence of these symptoms. Negativization was slower in patients who manifested 
dry cough (p=0.001), dyspnea (p=0.020) or throat pain (p=0.016). Negativization was 
also slower in those who developed Ig G (p=0.010) (Table 2) 
 Present Absent Breslow test 
Dry cough 28 (22-36) 23 (17-28) P=0.01 
Dyspnea 28 (21-39) 24 (19-33) P=0.02 
Throat pain 29 (21-40) 24 (19-33) P=0.016 




Table 2. Median, interquartile intervals and statistical signification (Breslow test) of 
those variables that influenced the speed of negativization using Kaplan-Meier curves. 
Time is expressed in days from disease onset. 
 
Cox regression analysis was performed, introducing age, gender, BMI and the three 
respiratory symptoms that were associated with the speed of negativization. Using the 
backward approach, two variables remained in the model (Dry cough and dyspnea). The 
adjusted hazard ratios were 0.61 (0.42-0.88), p=0.008 for dry cough and 0.68 (0.48-
0.96), p=0.027 for dyspnea, suggesting that the presence of one of these symptoms 
reduced the speed of negativization between 30% and 40%.(Table 3). 
Factor Hazard ratio (95% confidence interval) p 
Model (n=159)   
Dyspnea 0.677 (0.479-0.958) 0.027 
Dry cough 0.606 (0.419-0.876) 0.008 
 




RT-PCR, despite its limitations, is considered by most experts the gold standard for the 
diagnosis of COVID 19.(7) Managing healthcare workers represents additional 
challenges, because these workers may transmit the disease to vulnerable patients. Our 
current understanding of the viral kinetics in COVID‐19 is still incomplete, but recent 
findings suggest that infectivity and transmissibility may be lower after the initial 
illness, even with a positive PCR.(8) Recently, some groups have suggested that return 
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to work might be based on the evolution of cycle threshold and not in the dichotomized 
results of PCR. This, together with each center`s capacity for performing PCR, has led 
to significant heterogeneity in return to work protocols.  During the initial weeks of the 
pandemic, with a more limited knowledge of the disease, our guidelines considered that 
workers should not go back to work until they are symptom-free and the virus is no 
longer detected by PCR testing in the upper respiratory tract, in accordance with the 
initial recommendation of the CDC.(9)The strain the pandemic is exerting on healthcare 
systems requires their staff to rejoin their units as soon as possible. Due to the possible 
limitations on the number of PCRs that can be performed, it would be very useful to 
know the most efficient time after diagnosis to schedule a PCR prior to their 
reincorporation.  Furthermore, acquiring a greater knowledge of the impact of the 
pandemic in this population is important, because as Friese et al stated in a recent 
article: The health and well-being of our healthcare workers determine our nation’s 
health, security, and economic prosperity.(10) 
Most articles on  COVID-19 and health workers have discussed how to prepare (11), 
protect(10) or to screen (12, 13) them. To the best of our knowledge this is the first 
study that uses survival analysis to study RT-PCR negativization. A better 
understanding of the temporal behavior of RT-PCR could make healthcare worker 
management more efficient.  
 
We have observed that the disease appears abruptly and patients are able to pinpoint 
when they got sick. However, the cure is more gradual and in current practice patients 
undergo PCR when they feel better, not when they are completely cured. RT-PCR is 
usually performed when the patient`s respiratory symptoms have resolved. However we 
think that time intervals measured from symptom onset can be more precise, and that 
13 
 
this information should be taken in consideration to decide when the control RT-PCR is 
scheduled. 
Our workers needed a median time of 25 days from the onset of symptoms to 
negativizate RT-PCR. Gender, age and body mass index did not influence this process, 
despite their proven prognostic value. Neither did blood type. 
Although RT-PCR should be planned depending on the clinical scenario, our results 
suggest that doing a RT-PCR before three weeks of symptom onset yields low 
effectiveness. In the presence of respiratory symptoms (dyspnea, dry cough and throat 
pain), this test should be delayed one more week. This information may also be useful 
to guide the most appropriate time to return to work in less favored settings where the 
use of PCR is limited. 
A remarkable finding of our study is that the speed of negativization was slower in 
those who develop antibodies. The role of humoral response in the healing process has 
not been established yet, indeed a recent Cochrane review casts a lot of uncertainty on 
the utility of convalescent plasma.(14)  It seems reasonable to infer that if humoral 
immunity were the main mechanism for virus elimination those who develop antibodies 
would have eliminated the virus faster. This finding should be interpreted with caution 
as the serology test we employed was a qualitative test. Those patients that harbor the 
virus for a longer time are more prone to develop antibodies.  
Our work has some strengths and limitations. Survival analysis is the best way to 
estimate the expected duration of a biological or non-biological phenomenon. To the 
best of our knowledge this is the first study that has used survival analysis to evaluate 
PCR negativization in a group of healthcare workers. The main limitation is that 
information about the number of amplification cycles was not considered important at 
the time and thereby this information is not included in our analysis. As a recent 
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publication has highlighted, future studies should also consider RT-PCR amplification 
cycle threshold , which may be better correlated with viral load.(15) Nevertheless, we 
detected some clinical variables that were correlated with longer times to negativization 
and may be considered in the future for the development of return to work protocols. 
Other limitations are derived from the characteristics of our patients. Our sample is 
mainly composed of healthy, middle-age subjects, with a strong female predominance, 
and comorbidities were very uncommon. Thereby our sample is not ideal for evaluating 
the influence of comorbidities in this process. Not only young age and the unbalanced 
gender distribution are linked to a better prognosis. The mere fact that the studied 
subjects are workers makes the prognosis better, because workers represent the fittest 
part of a population. This bias, the so called healthy worker effect, is common to most 
cohort occupational studies.(16) Nevertheless, our results probably mirror accurately the 
composition of most healthcare systems, so our conclusions are applicable to most 
healthcare worker populations. Indeed a recent survey from the Center for Disease 
control (CDC) revealed a very similar distribution.(17)  
A further limitation is that most of our patients were managed without chest 
radiography and laboratory tests, although mild patients are usually managed thus and 
most healthcare workers do not develop severe forms of COVID. 
We conclude that time from disease onset can be an objective variable which may help 
to schedule control RT-PCT in infected healthcare workers. Performing this test before 
25 days after disease onset yields low effectiveness. However, in those patients who 
have been free of respiratory symptoms the test might be scheduled sooner, while in 
those who have developed respiratory symptoms it should be delayed. In our cohort 
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Figure 1. Recruitment algorithm 
Figure 2. Kaplan-Meier survival curves of the four variables that were associated with 
the speed of negativization (A. Development of IgG, B. Dry cough, C. Dyspnea, D. 
Throat pain) 
 
Table 1. Demographic data, main comorbidities and clinical manifestations during the 
course of disease. 
Table 2. Median, interquartile intervals and statistical signification (Breslow test) of 
those variables that influenced the speed of negativization using Kaplan-Meier curves. 
Time is expressed in days from disease onset. 
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